You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mesothelioma, Malignant

Showing 26 - 50 of 4,277
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Small Cell Lung Cancer (NSCLC), Malignant Pleural Mesothelioma (MPM) Trial in Marseille (Vinorelbine)

Completed
  • Non Small Cell Lung Cancer (NSCLC)
  • Malignant Pleural Mesothelioma (MPM)
  • Marseille, France
    Assistance Publique des Hôpitaux de Marseille (CEPCM)
Nov 15, 2022

Mesothelioma Patients and Their Family Members With Germline

Recruiting
  • Mesothelioma
  • Families
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Mesothelioma, Malignant, Mesothelioma, Malignant Pleural, Mesothelioma Malignant Advanced Trial in Beijing

    Not yet recruiting
    • Mesothelioma, Malignant
    • +2 more
    • Beijing, China
      Cancer Hospital Chinese Academy of Medical Sciences
    Dec 27, 2021

    Malignant Pleural Mesothelioma Trial in Philadelphia (OT-101)

    Not yet recruiting
    • Malignant Pleural Mesothelioma
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Jun 16, 2022

    Malignant Pleural Effusion, Malignant Pleural Mesothelioma, Mesothelioma Trial in Leicester (RSO-021)

    Recruiting
    • Malignant Pleural Effusion
    • +3 more
    • Leicester, United Kingdom
    • +5 more
    Oct 28, 2022

    Pleural Mesothelioma Trial in Italy (Carboplatin/Cisplatin - Pemetrexed - Pembrolizumab)

    Not yet recruiting
    • Pleural Mesothelioma
    • Carboplatin/Cisplatin - Pemetrexed - Pembrolizumab
    • Rozzano, MI, Italy
    • +5 more
    Nov 30, 2023

    Mesothelioma; Lung Trial in Toronto (Varying Doses of Background and Boost RT)

    Active, not recruiting
    • Mesothelioma; Lung
    • Varying Doses of Background and Boost RT
    • Toronto, Ontario, Canada
      Princess Margaret Hospital, University Health Network
    Oct 25, 2022

    Biphasic Mesothelioma, Epithelioid Mesothelioma, Peritoneal Malignant Mesothelioma Trial in Chicago (Pembrolizumab, Laboratory

    Active, not recruiting
    • Biphasic Mesothelioma
    • +9 more
    • Pembrolizumab
    • +2 more
    • Chicago, Illinois
      University of Chicago
    Apr 18, 2022

    Pleural Mesothelioma Trial in Rochester (Immunotherapy, Quality-of-Life Assessment, Stereotactic Body Radiation Therapy)

    Recruiting
    • Pleural Mesothelioma
    • Immunotherapy
    • +2 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 4, 2023

    Mesothelioma, Malignant Trial in Toronto (Cyclophosphamide, Tremelimumab, Durvalumab)

    Recruiting
    • Mesothelioma, Malignant
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    May 13, 2022

    Mesothelioma Trial in Boston (MPT Test, CLDN15/VIM Test)

    Recruiting
    • Mesothelioma
    • MPT Test
    • CLDN15/VIM Test
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Mar 21, 2022

    Mesothelioma, Malignant Trial in Leicester (Rucaparib, Abemaciclib, pembrolizumab & bemcentinib)

    Recruiting
    • Mesothelioma, Malignant
    • Leicester, United Kingdom
      University Hospitals of Leicester NHS Trust
    Apr 6, 2022

    Pleural Mesothelioma Malignant Advanced Trial in Spain, Switzerland, United Kingdom (Pembrolizumab, Gemcitabine, Vinorelbine)

    Completed
    Has Results
    • Pleural Mesothelioma Malignant Advanced
    • Barcelona, Spain
    • +14 more
    Aug 23, 2022

    Clear Cell Renal Cell Carcinoma Metastatic, TNBC - Triple-Negative Breast Cancer, Head Neck Cancer Trial (CA9hu-1)

    Not yet recruiting
    • Clear Cell Renal Cell Carcinoma Metastatic
    • +4 more
    • (no location specified)
    Jan 13, 2023

    Malignant Pleural Mesotheliomas (Mpm), Malignant Pleural Effusions (Mpe), Epithelial Tumors, Malignant Trial run by the National

    Not yet recruiting
    • Malignant Pleural Mesotheliomas (Mpm)
    • +4 more
    • Cytoreductive surgery
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Study of Patients With Malignant Mesothelioma

    Recruiting
    • Mesothelioma
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Apr 7, 2022

      Pleural Malignant Mesothelioma Trial in Houston (other, radiation, biological)

      Recruiting
      • Pleural Malignant Mesothelioma
      • Laboratory Biomarker Analysis
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      May 13, 2022

      Malignant Pleural Mesothelioma Trial in Houston (Dasatinib)

      Active, not recruiting
      • Malignant Pleural Mesothelioma
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Feb 25, 2022

      Mesothelioma Trial in Rochester (Cryotherapy, Control)

      Terminated
      • Mesothelioma
      • Cryotherapy
      • Control
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Jan 26, 2022

      Malignant Pleural Mesothelioma Trial in New York (Safety, Expansion Cohort)

      Recruiting
      • Malignant Pleural Mesothelioma
      • Safety
      • Expansion Cohort
      • New York, New York
        Icahn School of Medicine Mount Sinai
      Mar 31, 2022

      Mesothelioma, Pleural Mesothelioma, Wilms Tumor Trial in United States (Galinpepimut-S, Nivolumab, Sargramostim)

      Active, not recruiting
      • Mesothelioma
      • +2 more
      • Galinpepimut-S
      • +2 more
      • Basking Ridge, New Jersey
      • +5 more
      Nov 23, 2022

      Pleural Biphasic Mesothelioma, Pleural Sarcomatoid Mesothelioma Trial (Nivolumab, Ipilimumab, Surgical Procedure)

      Not yet recruiting
      • Pleural Biphasic Mesothelioma
      • Pleural Sarcomatoid Mesothelioma
      • Nivolumab
      • +5 more
      • (no location specified)
      Dec 9, 2022

      Peritoneal Carcinomatosis, Peritoneal Mesothelioma, Ovarian Cancer Trial run by the NCI (Mitomycin C, Cisplatin, Heated

      Recruiting
      • Peritoneal Carcinomatosis
      • +4 more
      • Mitomycin C
      • +6 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 28, 2023

      Clear Cell Renal Cell Carcinoma, Cervical Carcinoma, Esophageal Carcinoma Trial in Nashville (CTX131)

      Recruiting
      • Clear Cell Renal Cell Carcinoma
      • +4 more
      • CTX131
      • Nashville, Tennessee
        Research Site 1
      Mar 21, 2023

      Advanced Renal Cell Carcinoma, Advanced Mesothelioma, Advanced Osteosarcoma Trial in Houston (CAR.70/IL15-transduced CB-derived

      Not yet recruiting
      • Advanced Renal Cell Carcinoma
      • +2 more
      • CAR.70/IL15-transduced CB-derived NK cells
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 27, 2023